C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 451/02 (2006.01) A61K 31/46 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 15/00 (2006.01) A61P 15/10 (2006.01)
Patent
CA 2519939
Certain novel bicyclic N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Certains nouveaux dérivés de piperidine bicycliques N-acylés sont des agonistes du ou des récepteur(s) humain(s) de la mélanocortine et, en particulier, des agonistes sélectifs du récepteur humain 4 de la mélanocortine (MC-4R). On les utilise pour traiter, contrôler ou prévenir des maladies ou des troubles sensibles à l'activation de MC-4R, tels que l'obésité, les diabètes, le dysfonctionnement sexuel, notamment le dysfonctionnement de l'érection et un dysfonctionnement sexuel de la femme.
Guo Liangqin
Nargund Ravi P.
Ye Zhixiong
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Bicyclic piperidine derivatives as melanocortin-4 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic piperidine derivatives as melanocortin-4 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic piperidine derivatives as melanocortin-4 receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1681690